Adenosine in the central nervous system: Release mechanisms and extracellular concentrations

Journal of Neurochemistry

Volumn 79, Issue 3, 2001, Pages 463-484

  Latini, Serena ^a   Pedata, Felicita ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Adenosine release; CNS; Extracellular concentrations

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR;

BRAIN ELECTROPHYSIOLOGY; CENTRAL NERVOUS SYSTEM; CONCENTRATION (PARAMETERS); EXTRACELLULAR FLUID; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; NEUROPROTECTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN METABOLISM; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SYNAPSE;

ADENOSINE; ANIMALS; BRAIN; EXTRACELLULAR SPACE;

EID: 0034765853     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00607.x     Document Type: Review

References (182)

1. Demonstration of the existance of mRNAs encoding N1/cif and N2/cit sodium/nucleoside cotransporters in rat brain
2. Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain
3. Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain
4. Effect of propentophylline (HWA 285) on extracellular purine and excitatory amino acids in CA1 of rat hippocampus during transient ischemia
5. Striatal adenosine levels measured 'in vivo' by microdialysis in rats with an unilateral denervation
6. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: Inhibition of uptake and metabolism
7. In vivo release of adenosine from cat basal ganglia-studies with a push pull cannula
8. Use of an antagonist for estimating the degree of agonist stimulation during physiological release
9. Purine concentrations in the cerebrospinal fluid of unanesthetized rats during and after hypoxia
10. The cerebral acetylcholine release in conscious rabbits with semipermanently implanted epidural cups
11. The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices
12. Brain microdialysis
13. Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat
14. Adenosine-containing neurons in the brain localized by immunocytochemistry
15. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat
16. Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats
17. Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons
18. Metabolic regulation of endogenous adenosine release from single neurons
19. The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus
20. Involvement of calcium channels in depolarization-evoked release of adenosine from spinal cord synaptosomes
21. Kainate-evoked release of adenosine from the hippocampus of the anaesthetised rat: Possible involvement of free radicals
22. Adenosine deaminase increases release of excitatory amino acids through a mechanism independent of adenosine depletion
23. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice
24. Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in rat hippocampus in vivo
25. Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors
26. Electrical stimulation of the stratum radiatum increases the release and neosynthesis of aspartate, glutamate, and y-aminobutyric acid in rat hippocampal slices
27. N-Methyl-D-aspartate and non-N-methyl-D-aspartate- evoked adenosine release from rat cortical slices: Distinct purinergic sources and mechanisms of release
28. NMDA-evoked adenosine release from rat cortex does not require the intermediate formation of nitric oxide
29. Is cyclic AMP involved in excitatory amino acid-evoked adenosine release from rat cortical slices?
30. Ecto-5′-nucleotidase is associated with cholinergic nerve terminals in the hippocampus but not in the cerebral cortex of the rat
31. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices
32. 1 receptors
33. Immunological distinct isoforms of ecto-5′-nucleotidase in nerve terminals of different areas of the rat hippocampus
34. Delayed production of adenosine underlies temporal modulation of swimming in frog embryo
35. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice
36. Release of radiolabelled adenosine derivatives from superfused synaptosomes beds
37. Enhancement of NMDA-induced increases in levels of endogenous adenosine by adenosine deaminase and adenosine transport inhibition in rat striatum
38. Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation
39. Levels of endogenous adenosine in rat striatum. II. Regulation of basal and N-methyl-D-aspartate-induced levels by inhibitors of adenosine transport and metabolism
40. Levels of endogenous adenosine in rat striatum. I. Regulation by ionotropic glutamate receptors, nitric oxide and free radicals
41. Contribution of S-adenosylhomocysteine to cardiac adenosine formation
42. Analysis of purine and pyrimidine bases, nucleosides and deoxynucleosides in brain microsamples (microdialysates and micropunches) and cerebrospinal fluid
43. Sustained depolarisation induces changes in the extracellular concentrations of purine and pyrimidine nucleosides in the rat thalamus
44. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses
45. Adenosine neuromodulation
46. Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus
47. Adenine nucleotides undergo rapid quantitative conversion to adenosine in the extracellular space in rat hippocampus
48. Protective effect of adenosine and a novel xantine derivative propentophylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus
49. 2X receptor-mediated synapses in the rat brain: Why doesn't ATP kill the postsynaptic cells?
50. Changes in extracellular adenosine levels and population spike amplitude during graded hypoxia in the rat hippocampal slice
51. Heterogeneous localization of some purine enzymes in subcellular fractions of rat brain and cerebellum
52. Cell surface adenosine deaminase: Much more than an ectoenzyme
53. Nomenclature and classification of purinoceptors
54. Propentofylline and other adenosine transport inibitors increase the efflux of adenosine following electrical stimulation or metabolic stimulation of rat hippocampal slices
55. On the preparation of brain slices: Morphology and cyclic nucleotides
56. Distribution of adenosine deaminase activity in rat brain and spinal cord
57. Regulators of endogenous adenosine levels as therapeutic agents
58. Adenosine transport inhibition ameliorates postischemic hypoperfusion in pigs
59. The electrophysiology of adenosine in the mammalian central nervous system
60. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta
61. Monospecific antiserum against 5′-nucleotidase from Torpedo electric organ. Immunocytochemical distribution of the enzyme and its association with Schwann cell membranes
62. 2A receptor antagonist in MPTP-treated monkeys
63. 3H]adenosine from rat brain synaptosomal preparations
64. Blockade of N-methyl-D-aspartate-sensitive acidic amino acid receptors inhibits ischemia-induced accumulation of purine catabolites in the rat striatum
65. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia
66. Evidence for cAMP and cholate extrusion in C6 rat glioma cells by a common anion efflux pump
67. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis
68. + and glutamate
69. Glutamate-evoked release of endogenous adenosine from rat cortical synaptosomes is mediated by glutamate uptake and not by receptors
70. N-Methyl-D-aspartate, kainate and quisqualate release endogenous adenosine from rat cortical slices
71. +- and glutamate-evoked release of endogenous adenosine from rat cortical slices
72. Characteristic of the release of adenosine from slices of rat cerebral cortex
73. Adenosine receptors in neurological disorders
74. Production of adenosine from extracellular ATP at the striatal cholinergic synapse
75. Adenosine kinase inhibition protects brain against transient focal ischemia in rats
76. Release of purines, noradrenaline, and GABA from rat hippocampal slice by field stimulation
77. 2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys
78. Simple method for obtaining chronic CSF samples from awake rats
79. Brain acetylcholine, adenine nucleotides and their degradation products after intraperitoneal and intracerebral adenosine administration
80. Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport
81. Source of extracellular brain adenosine during hypoxia in fetal sheep
82. The source of brain adenosine outflow during ischemia and electrical stimulation
83. The contribution of different types of calcium channels to electrically-evoked adenosine release from rat hippocampal slices
84. Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions
85. Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices
86. Nucleoside transport in rat cerebralcortical synaptosomes. Evidences for two types of nucleoside transporters
87. Effect of adenosine versus adenine nucleotides on evoked potentials in a rat hippocampal slice preparation
88. A combined in vivo / in vitro study of the presynaptic release of adenosine derivatives in the hippocampus
89. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices
90. The transmethylation pathway as a source for adenosine in the isolated guinea-pig heart
91. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion
92. + and veratridine
93. Energy on demand
94. Immunocytochemical localization of ecto-5′-nucleotidase in cultures of cerebellar granule cells
95. Release of adenosine by activation of NMDA receptors in the hippocampus
96. Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine
97. Changes in hippocampal adenosine efflux, ATP levels, and synaptic transmission induced by increased temperature
98. Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia
99. Interaction between adenosine generated endogenously in neocortical tissues, and homocysteine and its thiolactone
100. Adenosine formation and release by embryonic chick neurons and glia in cell culture
101. Effect of N-methyl-D-aspartate on motor activity and in vivo adenosine striatal outflow in the rat
102. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion. Correlations with neurological deficit and histopathological damage
103. Pre- and peristroke treatment with the adenosine kinase inhibitor, 5′-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats
104. The spontaneous and evoked release of acetylcholine from the cerebral cortex
105. Purification and characterization of bovine brain 5′-nucleotidase
106. Anatomical and cytochemical relationships of adenosine deaminase-containing primary afferent neurons in the rat
107. 3H-nitrobenzylthioinosine and co-localization with adenosine deaminase
108. Immunohistochemistry of adenosine deaminase: Implications for adenosine neurotransmission
109. On the innervation of trigeminal mesencephalic primary afferent neurons by adenosine deaminase-containing projections from the hypothalamus in the rat
110. Adenosine deaminase and purinergic neuroregulation
111. Adenosine deaminase in rodent median eminence: Detection by antibody to the mouse enzyme and colocalization with adenosine deaminase complexing protein CD26
112. How does dipyridamole elevate extracellular adenosine concentration? Predictions from a three compartment model of adenosine formation and inactivation
113. Complex hippocampal responses to ATP: Fade due to nucleotidase inhibition and P2-receptor-mediated adenosine release
114. Adenosine in rat cerebral cortex: Its determination, normal values, and correlation to AMP and cyclic AMP during shortlasting ischemia
115. 2A adenosine receptors: An apparent paradox
116. A low-Km 5′-nucleotidase from rat brain cytosolic fraction: Purification, kinetic properties, and description of regulation by a novel factor that increases sensitivity to inhibition by ATP and ADP
117. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices
118. Effect of dipyridamole on cerebral extracellular adenosine level in vivo
119. Increased brain interstitial fluid adenosine concentration during hypoxia in newborn piglet
120. Localization of S-adenosylhomocysteine hydrolase and adenosine deaminase immunoreactivities in rat brain
121. + depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum
122. In vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors
123. Regulation of extracellular adenosine levels in the striatum of aging rats
124. Muscarinic modulation of purine release from elettrically stimulated rat cortical slices
125. Cholinergic and noradrenergic denervations decrease labelled purine release from electrically stimulated rat cortical slices
126. Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices
127. Endogenous adenosine release from hippocampal slices: Excitatory aminoacids agonists stimulate release, antagonists reduce the electrically evoked release
128. Adenosine outflow from hippocampal slices evoked by ischemic-like conditions: Effect of the excitatory ammo acid antagonists
129. Investigations into the adenosine outflow from hippocampal slices evoked by ischemic-like conditions
130. 2A receptors in ischemia
131. The release of acetylcholine from the rat brain: An approach to the study of central cholinergic mechanism
132. +-evoked amino acid and adenosine release from cerebellar neuronal cultures
133. Maximum activities, properties and distribution of 5′-nucleotidase, adenosine kinase and adenosine deaminase in rat and human brain
134. Acetylcholine release from cerebral cortex: Its role in cortical arousal
135. Adenosine in the control of the cerebral circulation
136. Deoxycoformycin antagonizes ischemia-induced neuronal degeneration
137. Increase in cerebral cortical perfusate adenosine and inosine concentrations during hypoxia and ischemia
138. Effects of deoxycoformycin on adenosine, inosine, hypoxanthine, xanthine, and uric acid release from the hypoxemic rat cerebral cortex
139. Effects of nifedipine and felodipine on adenosine and inosine release from the hypoxemic rat cerebral cortex
140. Effects of two nucleoside transport inhibitors, dipyridamole and soluflazine, on purine release from the rat cerebral cortex
141. Brain adenosine and transmitter amino acid release from the ischemic rat cerebral cortex: Effects of the adenosine deaminase inhibitor deoxycoformycin
142. Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion
143. The soluble 'low-Km' 5′-nucleotidase of rat kidney represents solubilized ecto-5′-nucleotidase
144. Depolarization-evoked accumulation of cyclic AMP in brain slice: The requisite intermediate adenosine is not derived from hydrolysis of released ATP
145. 14C] adenine nucleotides and their derivatives from cerebral tissues
146. Adenosine metabolism in a rat hippocampal slice preparation: Incorporation into S-adenosyl-homocysteine
147. Adenosine and cyclic AMP in cerebral cortex of rats in hypoxia, status epilepticus and hypercapnea
148. Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses
149. Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture
150. Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures
151. Neuroprotective role of adenosine in cerebral ischemia
152. 1 receptor in cultured neurons from rat cerebral cortex: Colocalization with adenosine deaminase
153. The mechanism of adenosine formation in cells - Cloning of cytosolic 5′-nucleotidase-I
154. Light and electron microscopical immunocytochemistry of 5′-nucleotidase in rat cerebellum
155. 5′-nucleotidase activity of mossy fibers in the dentate gyrus of normal and epileptic rats
156. Evidence for evoked release of adenosine and glutamate from cultured cerebellar granule cells
157. Increase of adenosine content in cerebral cortex of the cat during bicuculline-induced seizure
158. Increases in interstitial adenosine and cerebral blood flow with an inhibition of adenosine kinase and adenosine deaminase
159. Adenosine receptor blokade augments interstitial fluid levels of excitatory amino acids during cerebral ischemia
160. Changes in extracellular adenosine during chemical or electrical brain stimulation
161. Sources of adenosine released during neuromuscolar transmission in tha rat
162. Adenosine derived from hydrolysis of presynaptically released ATP inhibits neuromuscolar transmission in the rat
163. The organization and hypothalamic projections of the tuberomammillary nucleus in the rat: An immunohistochemical study of adenosine deaminase-positive neurons and fibers
164. 3H-adenosine and its derivatives from cat sensorimotor cortex
165. Adenosine release and uptake in cerebellar granule neurons both occur via an equilibrative nucleoside carrier that is modulated by G proteins
166. ATP release, adenosine formation, and modulation of dynorphin and glutamic acid release by adenosine analogues in rat hippocampal mossy fiber synaptosomes
167. Adenosine transporters
168. Measurement of neurotransmitter release by intracranial dialysis
169. 1-receptors
170. Adenosine and cerebral ischemia: Therapeutic future or death of a brave concept?
171. Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia
172. Potentiation of excitatory amino acid-evoked adenosine release from rat cortex by inibitors of adenosine kinase and adenosine deaminase and by cortex by acadesine
173. Brain adenosine production in the rat during 60 seconds of ischemia
174. Brain adenosine concentration during hypoxia in rats
175. 2 receptors to striatal neurons
176. Molecular cloning and functional characterization of nitrobenzylthioinosine NBMPR-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues
177. Purine levels in the intact brain, studies with an implanted perfused hollow fibre
178. Endogenous adenosine deaminase does not modulate synaptic transmission in rat hippocampal slices under normoxic or hypoxic conditions
179. 5′-Nucleotidase: Molecular structure and functional aspects
180. Signalling via ATP in the nervous system
181. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system
182. Hippocampal localization of 5′-nucleotidase as revealed by immunocytochemistry